Great Lakes Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.36M | Buy |
34,195
+1,737
| +5% | +$260K | 0.04% | 220 |
|
|
2026
Q1 | $4.96M | Buy |
32,458
+1,298
| +4% | +$199K | 0.04% | 227 |
|
|
2025
Q4 | $4.3M | Buy |
31,160
+627
| +2% | +$82.1K | 0.04% | 267 |
|
|
2025
Q3 | $3.92M | Buy |
30,533
+1,344
| +5% | +$164K | 0.03% | 291 |
|
|
2025
Q2 | $3.53M | Buy |
29,189
+2,235
| +8% | +$252K | 0.03% | 354 |
|
|
2025
Q1 | $3M | Buy |
26,954
+6,052
| +29% | +$644K | 0.03% | 374 |
|
|
2024
Q4 | $2.03M | Buy |
20,902
+2,048
| +11% | +$218K | 0.02% | 476 |
|
|
2024
Q3 | $2.17M | Buy |
18,854
+926
| +5% | +$105K | 0.02% | 473 |
|
|
2024
Q2 | $1.91M | Buy |
17,928
+14,976
| +507% | +$1.5M | 0.02% | 470 |
|
|
2024
Q1 | $286K | Buy |
2,952
+259
| +10% | +$26.6K | ﹤0.01% | 700 |
|
|
2023
Q4 | $272K | Sell |
2,693
-160
| -6% | -$15.4K | ﹤0.01% | 689 |
|
|
2023
Q3 | $291K | Buy |
2,853
+214
| +8% | +$21.7K | ﹤0.01% | 664 |
|
|
2023
Q2 | $266K | Hold |
2,639
| – | – | ﹤0.01% | 670 |
|
|
2023
Q1 | $243K | Hold |
2,639
| – | – | ﹤0.01% | 743 |
|
|
2022
Q4 | $239K | Hold |
2,639
| – | – | 0.01% | 598 |
|
|
2022
Q3 | $201K | Sell |
2,639
-24
| -0.9% | -$1.99K | ﹤0.01% | 612 |
|
|
2022
Q2 | $225K | Hold |
2,663
| – | – | ﹤0.01% | 625 |
|
|
2022
Q1 | $234K | Hold |
2,663
| – | – | ﹤0.01% | 646 |
|
|
2021
Q4 | $233K | Sell |
2,663
-100
| -4% | -$8.3K | ﹤0.01% | 633 |
|
|
2021
Q3 | $226K | Sell |
2,763
-168
| -6% | -$15.1K | ﹤0.01% | 635 |
|
|
2021
Q2 | $267K | Buy |
+2,931
| New | +$261K | ﹤0.01% | 604 |
|
|
2021
Q1 | – | Sell |
-2,440
| Closed | -$230K | – | 726 |
|
|
2020
Q4 | $230K | Buy |
+2,440
| New | +$213K | ﹤0.01% | 585 |
|
|
2019
Q2 | – | Sell |
-21,287
| Closed | -$1.83M | – | 554 |
|
|
2019
Q1 | $1.83M | Buy |
21,287
+557
| +3% | +$44.7K | 0.04% | 347 |
|
|
2018
Q4 | $1.59M | Buy |
20,730
+1,104
| +6% | +$85.9K | 0.04% | 346 |
|
|
2018
Q3 | $1.51M | Buy |
19,626
+826
| +4% | +$61.1K | 0.03% | 349 |
|
|
2018
Q2 | $1.27M | Buy |
18,800
+1,136
| +6% | +$78.4K | 0.03% | 363 |
|
|
2018
Q1 | $1.28M | Sell |
17,664
-1,947
| -10% | -$148K | 0.03% | 355 |
|
|
2017
Q4 | $1.48M | Sell |
19,611
-712
| -4% | -$53.7K | 0.03% | 349 |
|
|
2017
Q3 | $1.56M | Sell |
20,323
-582
| -3% | -$44K | 0.04% | 332 |
|
|
2017
Q2 | $1.56M | Sell |
20,905
-228
| -1% | -$16.2K | 0.04% | 321 |
|
|
2017
Q1 | $1.41M | Sell |
21,133
-702
| -3% | -$46.8K | 0.04% | 313 |
|
|
2016
Q4 | $1.43M | Sell |
21,835
-215
| -1% | -$13.9K | 0.04% | 308 |
|
|
2016
Q3 | $1.56M | Buy |
22,050
+268
| +1% | +$19.5K | 0.04% | 298 |
|
|
2016
Q2 | $1.61M | Sell |
21,782
-66
| -0.3% | -$4.56K | 0.04% | 302 |
|
|
2016
Q1 | $1.42M | Buy |
21,848
+454
| +2% | +$30.9K | 0.04% | 307 |
|
|
2015
Q4 | $1.65M | Buy |
21,394
+238
| +1% | +$18.9K | 0.05% | 270 |
|
|
2015
Q3 | $1.74M | Buy |
21,156
+5,005
| +31% | +$445K | 0.05% | 258 |
|
|
2015
Q2 | $1.42M | Buy |
16,151
+1,748
| +12% | +$160K | 0.04% | 278 |
|
|
2015
Q1 | $1.27M | Buy |
14,403
+978
| +7% | +$86.7K | 0.04% | 299 |
|
|
2014
Q4 | $1.11M | Buy |
13,425
+1,040
| +8% | +$86.2K | 0.03% | 294 |
|
|
2014
Q3 | $1.04M | Sell |
12,385
-157
| -1% | -$12.7K | 0.04% | 289 |
|
|
2014
Q2 | $1.02M | Buy |
12,542
+479
| +4% | +$37.7K | 0.04% | 196 |
|
|
2014
Q1 | $919K | Sell |
12,063
-46
| -0.4% | -$3.35K | 0.04% | 205 |
|
|
2013
Q4 | $872K | Buy |
12,109
+1,249
| +12% | +$86.8K | 0.04% | 177 |
|
|
2013
Q3 | $747K | Buy |
10,860
+178
| +2% | +$11.8K | 0.03% | 198 |
|
|
2013
Q2 | $677K | Buy |
+10,682
| New | +$695K | 0.03% | 197 |
|
Other funds holding NVS
Great Lakes Advisors's NVS Position: Q2 2026 in Review
Great Lakes Advisors increased its Novartis (NVS) stake by 5.4% in Q2 2026, buying an estimated $260K and bringing the position to 34,195 shares worth $5.36M. The position accounts for 0.04% of the portfolio, ranked #220.
Great Lakes Advisors first reported a position in NVS in Q2 2013 and has held it in 46 quarters since. 1,625 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Great Lakes Advisors held 34,195 shares of Novartis worth $5.36M as of Q2 2026.
- Great Lakes Advisors bought 1,737 Novartis shares in Q2 2026, an estimated $260K.
- Novartis made up 0.04% of Great Lakes Advisors's portfolio in Q2 2026, its #220 holding.
- Great Lakes Advisors first reported a position in Novartis in Q2 2013 and has held it in 46 quarters since.
- 1,625 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Great Lakes Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.